Incyte Competitors and Similar CompaniesClear all
Incyte's competitors and similar companies include Biogen, Fujifilm Diosynth Biotechnologies, Chiesi Group and YiChang HEC ChangJiang Pharmaceutical.
 Incyte Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. |  YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. | |
Founding Date | Founding Date 1991 | Founding Date 1978 | Founding Date 2011 | Founding Date 1935 | Founding Date 2001 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Wilmington, US HQ Wien, AT Pointe Claire, CA Frederiksberg, DK Boulogne Billancourt, FR München, DE Milano, IT see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more | Locations HQ |
Employees | Employees 1,4567% increase | Employees 7,605 | Employees 5,3942% increase | Employees 5,8541% increase | Employees 4,595 |
Valuation ($) | Valuation ($) 14.2 b | Valuation ($) 26.7 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $5.1b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €2.4b (Y, 2021) | Revenue (est.) ¥3.7b (FY, 2024) |
Cost of goods | Cost of goods $372.1m (FY, 2025) | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥533.6m (FY, 2024) |
Gross profit | Gross profit $4.8b (FY, 2025) | Gross profit $7.5b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ¥3.2b (FY, 2024) |
Net income | Net income $1.3b (FY, 2025) | Net income $1.3b (FY, 2025) | Net income N/A | Net income N/A | Net income ¥482.7m (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyFujifilm Diosynth Biotechnologies
HQ
Morrisville, US
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
View companyChiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View companyYiChang HEC ChangJiang Pharmaceutical
HQ
Employees
4,595
YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
View company